marijuana stocks news

GW Pharmaceuticals to Report Q1 Financial Results and Host Conference Call on 7 February, 2017

GW Pharmaceuticals plc (GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, will announce on 7 February, 2017 its first quarter financial results for the period ending 31 December, 2016. GW will also host a conference call the same day at 8:30 a.m. EST. Conference call information will be provided in the financial results press release. A replay of the call will also be available through the Company’s website (www.gwpharm.com) shortly after the call.

About GW Pharmaceuticals plc

Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. GW is advancing an orphan drug program in the field of childhood epilepsy with a focus on Epidiolex® (cannabidiol), which is in Phase 3 clinical development for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, Tuberous Sclerosis Complex and Infantile Spasms. GW commercialized the world’s first plant-derived cannabinoid prescription drug, Sativex®, which is approved for the treatment of spasticity due to multiple sclerosis in 31 countries outside the United States. The Company has a deep pipeline of additional cannabinoid product candidates which includes compounds in Phase 1 and 2 trials for glioma, schizophrenia and epilepsy. For further information, please visit www.gwpharm.com.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Premier Health Group ( PHGRF ) Announces Binding LOI to Acquire Operating Pharmacy

Premier Health Announces Binding LOI to Acquire Operating Pharmacy Premier Health Group…

Neptune Wellness Solutions Inc. (NEPT) Issues Letter to Shareholders

Neptune Wellness Issues Letter to Shareholders Neptune Wellness Solutions Inc. (“Neptune” or…

Reliq Health Technologies Inc. (RQHTF) Announces Go-Live with Paz Home Health

Reliq Health Technologies Announces Go-Live with Paz Home Health, USA – >$6MMUSD…

Lexaria Bioscience Corp. (LXRP) Files New Patent Utilizing DehydraTECH Technology

Lexaria Bioscience Files New Patent Utilizing DehydraTECH Technology for Treatment of Infectious…